G Doug Iiekking Net Worth

The estimated Net Worth of G Doug Iiekking is at least $1.82 Million dollars as of 8 February 2024. G Iiekking owns over 2,321 units of Usana Health Sciences Inc stock worth over $243,438 and over the last 21 years G sold USNA stock worth over $1,577,853.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

G Iiekking USNA stock SEC Form 4 insiders trading

G has made over 26 trades of the Usana Health Sciences Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently G sold 5,198 units of USNA stock worth $232,662 on 7 May 2024.

The largest trade G's ever made was exercising 8,010 units of Usana Health Sciences Inc stock on 26 July 2012 worth over $228,445. On average, G trades about 1,979 units every 105 days since 2003. As of 8 February 2024 G still owns at least 6,530 units of Usana Health Sciences Inc stock.

You can see the complete history of G Iiekking stock trades at the bottom of the page.

What's G Iiekking's mailing address?

G's mailing address filed with the SEC is 3838 WEST PARKWAY BLVD, , SALT LAKE CITY, UT, 84120.

Insiders trading at Usana Health Sciences Inc

Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull, and Myron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.

What does Usana Health Sciences Inc do?

usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su

Complete history of G Iiekking stock trades at Usana Health Sciences Inc

Usana Health Sciences Inc executives and stock owners

Usana Health Sciences Inc executives and other stock owners filed with the SEC include:

• Kevin Guest,
  Chairman of the Board, Chief Executive Officer
• Jim Brown,
  President
• Kevin G. Guest,
  Chairman & CEO
• G Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Field Development Officer
• Walter Noot,
  Chief Operating Officer
• Jim Brown,
  Pres
• Daniel Macuga,
  Chief Communications and Marketing Officer
• G. Douglas Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Sales Officer
• Walter Noot,
  Chief Operating Officer
• Paul Jones,
  Chief Leadership Development Officer
• Peggie Pelosi,
  Independent Director
• Gilbert Fuller,
  Lead Independent Director
• Robert Anciaux,
  Senior Director
• Frederic Winssinger,
  Independent Director
• Feng Peng,
  Independent Director
• Timothy Wood,
  Independent Director
• Dr. Myron W. Wentz,
  Founder & Chairman Emeritus
• John Fleming,
  Director
• Brent Neidig,
  Chief Officer and Managing Director of China
• P. Joshua Foukas,
  Chief Legal Officer, General Counsel and Corporate Secretary
• Robert Sinnott,
  Chief Scientific Officer
• P. Joshua Foukas,
  Chief Legal Officer, Gen. Counsel & Corp. Sec.
• Patrique Richards,
  Exec. Director of Investor Relations & Bus. Devel.
• Dr. John Cuomo,
  Exec. Director of Product Devel. & Technology
• J Scott Nixon,
  Director
• Myron W Gull Global Ltd Wentz,
  
• Robert Auciaux,
  
• Global Ltd Gull,
  10% owner
• Myron W Wentz,
  CEO
• Deborah Woo,
  E.V.P. of Sales
• Donald R. Williams,
  Director
• Dave Wentz,
  President
• James Bramble,
  
• Jerry G Mcclain,
  Director
• Denis E Waitley,
  Director
• Roy Truett,
  Chief Information Officer
• Doug Braun,
  Chief Marketing Officer
• Ronald S Poelman,
  Director
• Rick Stambaugh,
  Chief Information Officer
• Holdings Ltd Gull,
  10% owner
• Fred W Cooper,
  Vice President of Operations
• Jeffrey Yates,
  Chief Financial Officer
• Mark H Wilson,
  V.P. of Customer Relations
• Bradford Richardson,
  E.V.P. of Asia Pacific
• G Doug Iiekking,
  CHIEF FINANCIAL OFFICER
• Peter Benedict,
  CHIEF INFORMATION OFFICER
• Joshua Foukas,
  CHIEF LEGAL OFFICER
• Xia Ding,
  Director